Victor Forge
Skeletal muscle is the largest organ in the body and plays a crucial role in insulin-stimulated glucose disposal. Insulin's control of glucose metabolism in skeletal muscle is complex and highly regulated, with exercise increasing the sensitivity of skeletal muscle to insulin stimulation. Insulin resistance in skeletal muscle is a core defect in type 2 diabetes and is associated with obesity and metabolic syndrome. While the specific role of insulin receptor (IR) overexpression in muscle is unclear, studies in mice have shown that muscle-specific IR overexpression can protect against diet-induced glucose intolerance. Additionally, genes such as Sirt2 and HK-II have been implicated in insulin sensitivity and resistance, respectively.
| Characteristics | Values |
|---|---|
| Insulin's role in skeletal muscle | Pivotal in metabolic homeostasis |
| Importance of skeletal muscle | Primary driver of whole-body glycemic control |
| Skeletal muscle and insulin resistance | Skeletal muscle insulin resistance is among the first detectable defects in humans with type 2 diabetes |
| Genes correlated to insulin sensitivity in skeletal muscle | CPT1B, SIRT2, FBXW5 |
| Genes correlated to insulin resistance in skeletal muscle | IRS-1, PGC-1 |
Explore related products
What You'll Learn
Insulin resistance in skeletal muscle
The accumulation of lipid intermediates in skeletal muscle cells has been linked to defects in the insulin signalling cascade, leading to a decrease in insulin-stimulated glucose uptake and metabolism, resulting in insulin resistance. This accumulation of lipids is more commonly seen in long-chain saturated FA species such as palmitic, stearic, and arachidic esters.
Myonectin has been found to mimic insulin's ability to promote fatty acid uptake by upregulating the expression of fatty acid transport genes in response to exercise. Myonectin can also inhibit autophagy in the mouse liver, and this ability is abolished when the phosphatidylinositol-3 kinase (PI3K)/AKT pathway is suppressed. The PI3K/AKT pathway is important in skeletal muscle anabolism, and myonectin may act through this pathway to inhibit muscle atrophy and promote muscle growth.
Exercise has been shown to be a therapeutic intervention for insulin resistance in skeletal muscle. A single session of aerobic exercise increases glucose uptake by skeletal muscle, increases insulin's ability to promote glucose uptake, and increases glycogen accumulation after exercise, all of which are important for blood glucose control. Additionally, exercise mimetics have been explored as a potential therapeutic agent for insulin resistance.
Genes regulating insulin sensitivity in skeletal muscle have also been studied. CPT1B, SIRT2, and FBXW5 expression have been positively correlated with insulin sensitivity. These genes have also been positively correlated with the expression of genes promoting the phenotype of an insulin-sensitive myocyte, such as the transport and mitochondrial uptake and oxidation of fatty acids, and positive regulation of mitochondrial biogenesis and oxidative phosphorylation.
Muscle Beach: Free Access to Fitness and Fun
You may want to see also
Explore related products
Genes correlated to insulin sensitivity
Genes play a crucial role in insulin sensitivity, and various studies have explored the relationship between insulin sensitivity and gene expression in human skeletal muscle. Skeletal muscle is the principal tissue for insulin-stimulated glucose disposal, and it uniquely responds to muscle contraction or exercise by increasing its sensitivity to subsequent insulin stimulation.
One study identified 70 genes positively and 110 genes inversely correlated with insulin sensitivity in human skeletal muscle. Among these, SIRT2 and FBXW5 stood out for their involvement in lipid metabolism and regulation of mammalian target-of-rapamycin (mTOR) and autophagy. CPT1B was also positively correlated with insulin sensitivity, along with SIRT2 and FBXW5. These genes are associated with the expression of key genes that promote the phenotype of an insulin-sensitive myocyte, such as the transport and mitochondrial uptake of fatty acids.
Additionally, the GLUT4 glucose transporter, encoded by the SCL2A4 gene, is highly abundant in skeletal muscle and adipose tissue. GLUT4 is an intracellular protein that relies on stimuli like insulin or exercise to move to the plasma membrane and facilitate glucose uptake. Other glucose transporters, like GLUT1 and GLUT3, are also involved in glucose uptake in skeletal muscle.
Large-scale genome-wide association studies have helped identify common genetic variations associated with insulin resistance and metabolic syndrome. These studies have revealed that many variants associated with insulin resistance are directly involved in glucose metabolism. However, functional studies are still needed to fully understand their contribution to the development of insulin resistance.
While surrogate measures of insulin resistance, such as serum insulin concentrations, are easier and less invasive, direct measures like the euglycemic hyperinsulinemic clamp provide more definitive assessments of insulin action. The search for genes influencing insulin sensitivity continues, with strategies ranging from studying intermediate phenotypes to seeking disease genes directly.
Building Show Muscles: A Step-by-Step Guide
You may want to see also
Explore related products
Insulin-stimulated glucose disposal
The importance of skeletal muscle in insulin-stimulated glucose disposal is further emphasized in the context of metabolic diseases, particularly Type 2 Diabetes (T2D). T2D is characterized by peripheral insulin resistance, which impairs the body's ability to effectively utilize glucose. This impairment, known as Insulin-Stimulated Whole-Body Glucose Disposal (ISGD), is a physiological phenomenon that hinders glucose uptake during an excess of endogenous or exogenous lipids. Interestingly, ISGD is not only reduced in patients with overt T2D but is also present in normoglycemic individuals with a family history of T2D, highlighting the influence of genetic factors.
Thioctic acid (TA), a naturally occurring compound, has emerged as a promising pharmacological intervention for improving insulin sensitivity and enhancing glucose utilization in patients with T2D. Clinical studies have demonstrated that repeated parenteral administration of TA can significantly increase insulin-stimulated glucose disposal, even in the presence of insulin resistance. This discovery underscores the potential of TA in managing T2D and improving metabolic outcomes for affected individuals.
In summary, insulin-stimulated glucose disposal is a complex process that primarily occurs in skeletal muscle, with peripheral tissues also contributing. This process is integral to maintaining whole-body glycemic control and is closely linked to metabolic diseases like T2D. The discovery of TA's beneficial effects on insulin sensitivity offers new hope for therapeutic interventions aimed at improving glucose disposal and mitigating the impact of insulin resistance in T2D patients. Further research and clinical trials are warranted to build upon these initial findings and optimize treatment strategies.
Muscle Knots: Swelling, Pain, and Treatment Options
You may want to see also
Explore related products
Insulin sensitivity in type 2 diabetes patients
Insulin resistance is a key feature of prediabetes and type 2 diabetes. It can also affect those with type 1 diabetes. Insulin resistance is caused by a decreased sensitivity to insulin, resulting in the need for higher insulin levels to manage blood glucose levels effectively. This can lead to hyperglycaemia, which is a precursor to prediabetes and type 2 diabetes.
The development of insulin resistance is influenced by both genetic and environmental factors. Certain inherited genetic disorders, such as Type A insulin resistance syndrome, Donohue syndrome, myotonic dystrophy, Alström syndrome, Werner syndrome, and inherited lipodystrophy, can cause insulin resistance. Additionally, having a family history of insulin resistance or type 2 diabetes increases the risk of developing the condition. Obesity, physical inactivity, and age are also contributing factors to insulin resistance.
Skeletal muscle plays a crucial role in insulin resistance and glucose uptake. Insulin acts on skeletal muscle to regulate metabolic homeostasis, and any disruption in this process can lead to metabolic diseases, including insulin resistance, type 2 diabetes, obesity, and sarcopenia. Exercise has been found to significantly reduce insulin resistance and improve blood glucose control. This is achieved by increasing the body's sensitivity to insulin, building muscle that can absorb blood glucose, and providing an alternative pathway for glucose to enter muscle cells without relying on insulin.
Studies have investigated the relationship between insulin sensitivity and gene expression in human skeletal muscle. Genes such as CPT1B, SIRT2, and FBXW5 have been positively correlated with insulin sensitivity. These genes are involved in promoting the phenotype of an insulin-sensitive myocyte, including the transport and mitochondrial uptake of fatty acids, as well as regulating mitochondrial biogenesis and oxidative phosphorylation. Additionally, myonectin has been found to mimic insulin's ability to promote fatty acid uptake by upregulating the expression of fatty acid transport genes in response to exercise.
In summary, insulin sensitivity in type 2 diabetes patients is a complex interplay between genetic predispositions and lifestyle factors. While some genes are associated with increased or decreased insulin sensitivity, lifestyle modifications, particularly exercise, play a crucial role in improving insulin sensitivity and managing type 2 diabetes.
Muscle Recovery: How Do I Know I'm Recovered?
You may want to see also
Explore related products
Insulin's role in muscle contraction or exercise
Skeletal muscle is the principal tissue for insulin-stimulated glucose disposal and is a primary driver of whole-body glycemic control. Insulin's control of glucose metabolism is highly regulated and complex, with diverse and unique effects on skeletal muscle.
During exercise, there is an increase in the delivery of glucose and insulin to the muscle as a result of increased muscle blood flow. This increase in blood flow and insulin sensitivity may be associated with the activation of the kinin-prostaglandin system of the muscle. The increase in insulin sensitivity may also be due to an increase in insulin binding to its receptors on the sarcolemma, which requires the presence of epinephrine.
Exercise-induced muscle contraction can also induce the secretion of novel, previously unidentified myokines, which have anti-inflammatory potential. Myonectin, a myokine, can inhibit muscle atrophy and promote muscle growth by activating the PI3K/AKT pathway, which is important in skeletal muscle anabolism. Myonectin also activates the AMPK pathway, leading to increased translocation of the GLUT4 glucose transporter and glucose uptake.
Prolonged, moderately intense exercise increases glucose uptake as muscle glycogen levels decline. This increase in glucose uptake is inversely related to the glucose-6-phosphate concentration of the cell. It has been found that the increase in membrane permeability following contractile activity can persist for many hours, unlike insulin-stimulated glucose transport, where permeability rapidly reverses upon the removal of insulin.
Blood Vessels and Cardiac Muscle: What's the Relationship?
You may want to see also
Frequently asked questions
No, muscles do not have the insulin gene. However, skeletal muscle insulin resistance is one of the first detectable issues in people with type 2 diabetes.
The insulin gene is responsible for producing the insulin protein, which regulates blood sugar levels in the body.
Skeletal muscle plays a crucial role in metabolic diseases, including insulin resistance, diabetes, obesity, aging, and sarcopenia. It is the primary tissue for insulin-stimulated glucose disposal, and exercise increases its sensitivity to insulin stimulation.
Insulin resistance in skeletal muscle is caused by impaired insulin signaling and multiple post-receptor intracellular defects, including impaired glucose transport, glucose phosphorylation, and reduced glucose oxidation and glycogen synthesis. It is closely associated with type 2 diabetes, obesity, and metabolic syndrome.
![COLOSSAL LABS Muscle Protein Whey Powder [12 lbs/Pack of 1]– Cold Filtered, 25g Pure Protein, 6.6g BCAAs (Packaging May Vary) (12LB, Peanut Butter Chocolate)](https://m.media-amazon.com/images/I/81Lf5lxm7RL._AC_UL320_.jpg)
